HRP20070574T3 - Antimycobacterial pharmaceutical composition comprising an antitubercular drug - Google Patents

Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Info

Publication number: HRP20070574T3
Authority: HR; Croatia
Prior art keywords: pharmaceutical composition; antimycobacterial; antitubercular drug; antimycobacterial pharmaceutical; methyl
Prior art date: 2004-05-12

Application number

HR20070574T

Other languages

English (en)

Croatian (hr)

Inventor

Kumar Arora Sudershan

Sinha Neelima

Sinha Rakesh

Shankar Upadhyaya Ram

Original Assignee

Lupin Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2004-08-27

Publication date

2008-01-31

2004-08-27 Application filed by Lupin Limited filed Critical Lupin Limited

2008-01-31 Publication of HRP20070574T3 publication Critical patent/HRP20070574T3/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HR20070574T 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug HRP20070574T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/844,992 US7491721B2 (en)	2004-05-12	2004-05-12	Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (fr)	2004-05-12	2004-08-27	Composition pharmaceutique antimycobacterienne

Publications (1)

Publication Number	Publication Date
HRP20070574T3 true HRP20070574T3 (en)	2008-01-31

Family

ID=34960626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20070574T HRP20070574T3 (en)	2004-05-12	2004-08-27	Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Country Status (44)

Country	Link
US (1)	US7491721B2 (fr)
EP (1)	EP1750765B1 (fr)
JP (1)	JP2007537242A (fr)
KR (1)	KR100854309B1 (fr)
CN (1)	CN1956732B (fr)
AP (1)	AP1994A (fr)
AR (1)	AR048948A1 (fr)
AT (1)	ATE373488T1 (fr)
AU (1)	AU2004319259A1 (fr)
BR (1)	BRPI0418770A (fr)
CA (1)	CA2566440C (fr)
CR (1)	CR8748A (fr)
DE (1)	DE602004009113T2 (fr)
DK (1)	DK1750765T3 (fr)
DO (1)	DOP2005000085A (fr)
EA (1)	EA009694B1 (fr)
EC (1)	ECSP066965A (fr)
ES (1)	ES2294577T3 (fr)
GE (1)	GEP20094805B (fr)
HN (1)	HN2005000210A (fr)
HR (1)	HRP20070574T3 (fr)
IL (1)	IL178858A (fr)
IS (1)	IS8559A (fr)
JO (1)	JO2471B1 (fr)
MA (1)	MA28603B1 (fr)
MX (1)	MXPA06012984A (fr)
MY (1)	MY139187A (fr)
NI (1)	NI200600270A (fr)
NO (1)	NO20065725L (fr)
NZ (1)	NZ550892A (fr)
PA (1)	PA8633001A1 (fr)
PE (1)	PE20060353A1 (fr)
PL (1)	PL1750765T3 (fr)
PT (1)	PT1750765E (fr)
RS (1)	RS20060624A (fr)
SA (1)	SA05260130B1 (fr)
SI (1)	SI1750765T1 (fr)
SM (1)	SM200500011B (fr)
SV (1)	SV2006002109A (fr)
TN (1)	TNSN06349A1 (fr)
UA (1)	UA82782C2 (fr)
UY (1)	UY28893A1 (fr)
WO (1)	WO2005107809A2 (fr)
ZA (1)	ZA200608843B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006233943A1 (en) *	2005-04-11	2006-10-19	Lupin Limited	Preparation of (2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)) pyrrole derivatives
JP5339840B2 (ja)	2008-10-02	2013-11-13	公益財団法人微生物化学研究会	抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) *	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
MX2012002910A (es) *	2009-09-11	2012-04-19	Vertex Pharma	Composiciones de n-bencil-3-(4-clorofenil)-2-[metil-[2-oxo-2-(3,4, 5-trietoxifenil)acetil]amino]-n-[3-(4-piridil)-1-[2-(4-piridil)et il]propil]propanamida y usos de las misma.
HUP1000033A2 (en) *	2010-01-21	2011-07-28	Uratim Kft	Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) *	2021-10-20	2022-11-03	순천향대학교 산학협력단	신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN117045657A (zh) *	2022-05-12	2023-11-14	广州嘉越医药科技有限公司	一种药物组合及其应用
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same
CN118743705B (zh) *	2024-08-12	2024-11-15	深圳大学	药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5227383A (en) *	1991-06-14	1993-07-13	The University Of Mississippi	Compounds and compositions useful as antifungal and antimycobacterial agents
AU2002343200B2 (en) *	2002-09-20	2009-08-13	Lupin Limited	Pyrrole derivatives as antimycobacterial compounds

2004
- 2004-05-12 US US10/844,992 patent/US7491721B2/en not_active Expired - Fee Related
- 2004-08-27 NZ NZ550892A patent/NZ550892A/en unknown
- 2004-08-27 CA CA002566440A patent/CA2566440C/fr not_active Expired - Fee Related
- 2004-08-27 PL PL04816650T patent/PL1750765T3/pl unknown
- 2004-08-27 RS YUP-2006/0624A patent/RS20060624A/sr unknown
- 2004-08-27 AP AP2006003807A patent/AP1994A/xx active
- 2004-08-27 EP EP04816650A patent/EP1750765B1/fr not_active Expired - Lifetime
- 2004-08-27 MX MXPA06012984A patent/MXPA06012984A/es active IP Right Grant
- 2004-08-27 WO PCT/IN2004/000266 patent/WO2005107809A2/fr not_active Ceased
- 2004-08-27 KR KR1020067023513A patent/KR100854309B1/ko not_active Expired - Fee Related
- 2004-08-27 AU AU2004319259A patent/AU2004319259A1/en not_active Abandoned
- 2004-08-27 JP JP2007512723A patent/JP2007537242A/ja active Pending
- 2004-08-27 HR HR20070574T patent/HRP20070574T3/xx unknown
- 2004-08-27 DK DK04816650T patent/DK1750765T3/da active
- 2004-08-27 SI SI200430552T patent/SI1750765T1/sl unknown
- 2004-08-27 UA UAA200612258A patent/UA82782C2/uk unknown
- 2004-08-27 AT AT04816650T patent/ATE373488T1/de active
- 2004-08-27 CN CN2004800431312A patent/CN1956732B/zh not_active Expired - Fee Related
- 2004-08-27 DE DE602004009113T patent/DE602004009113T2/de not_active Expired - Lifetime
- 2004-08-27 EA EA200601952A patent/EA009694B1/ru not_active IP Right Cessation
- 2004-08-27 GE GEAP20049749A patent/GEP20094805B/en unknown
- 2004-08-27 BR BRPI0418770-9A patent/BRPI0418770A/pt not_active IP Right Cessation
- 2004-08-27 ES ES04816650T patent/ES2294577T3/es not_active Expired - Lifetime
- 2004-08-27 PT PT04816650T patent/PT1750765E/pt unknown
2005
- 2005-05-11 AR ARP050101898A patent/AR048948A1/es not_active Application Discontinuation
- 2005-05-11 SV SV2005002109A patent/SV2006002109A/es not_active Application Discontinuation
- 2005-05-11 MY MYPI20052107A patent/MY139187A/en unknown
- 2005-05-11 DO DO2005000085A patent/DOP2005000085A/es unknown
- 2005-05-11 UY UY28893A patent/UY28893A1/es unknown
- 2005-05-11 PE PE2005000526A patent/PE20060353A1/es not_active Application Discontinuation
- 2005-05-12 JO JO200559A patent/JO2471B1/en active
- 2005-05-12 SM SM200500011A patent/SM200500011B/it unknown
- 2005-05-12 PA PA20058633001A patent/PA8633001A1/es unknown
- 2005-05-12 HN HN2005000210A patent/HN2005000210A/es unknown
- 2005-05-14 SA SA5260130A patent/SA05260130B1/ar unknown
2006
- 2006-10-24 ZA ZA200608843A patent/ZA200608843B/xx unknown
- 2006-10-25 IL IL178858A patent/IL178858A/en not_active IP Right Cessation
- 2006-10-26 IS IS8559A patent/IS8559A/is unknown
- 2006-10-30 TN TNP2006000349A patent/TNSN06349A1/en unknown
- 2006-10-30 EC EC2006006965A patent/ECSP066965A/es unknown
- 2006-11-10 NI NI200600270A patent/NI200600270A/es unknown
- 2006-11-10 CR CR8748A patent/CR8748A/es not_active Application Discontinuation
- 2006-11-23 MA MA29484A patent/MA28603B1/fr unknown
- 2006-12-12 NO NO20065725A patent/NO20065725L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1750765B1 (fr)	2007-09-19
DE602004009113D1 (de)	2007-10-31
HN2005000210A (es)	2009-03-17
NO20065725L (no)	2006-12-12
AU2004319259A1 (en)	2005-11-17
HK1098962A1 (en)	2007-08-03
PT1750765E (pt)	2007-12-31
MY139187A (en)	2009-08-28
PA8633001A1 (es)	2006-12-07
CA2566440C (fr)	2009-08-04
US20050256128A1 (en)	2005-11-17
EA200601952A1 (ru)	2007-02-27
MXPA06012984A (es)	2007-04-23
TNSN06349A1 (en)	2008-02-22
PE20060353A1 (es)	2006-07-08
WO2005107809A3 (fr)	2006-01-26
AR048948A1 (es)	2006-06-14
AP2006003807A0 (en)	2006-12-31
WO2005107809A2 (fr)	2005-11-17
DOP2005000085A (es)	2007-01-15
KR100854309B1 (ko)	2008-08-26
IS8559A (is)	2006-10-26
DE602004009113T2 (de)	2008-06-19
ZA200608843B (en)	2008-07-30
ES2294577T3 (es)	2008-04-01
SV2006002109A (es)	2006-04-18
PL1750765T3 (pl)	2008-02-29
SM200500011A (it)	2005-11-16
MA28603B1 (fr)	2007-05-02
ECSP066965A (es)	2006-12-20
IL178858A0 (en)	2007-03-08
UA82782C2 (uk)	2008-05-12
SM200500011B (it)	2005-11-16
CR8748A (es)	2008-06-02
IL178858A (en)	2010-06-16
US7491721B2 (en)	2009-02-17
RS20060624A (sr)	2008-09-29
CN1956732A (zh)	2007-05-02
NZ550892A (en)	2009-12-24
CA2566440A1 (fr)	2005-11-17
GEP20094805B (en)	2009-10-26
DK1750765T3 (da)	2008-01-28
EA009694B1 (ru)	2008-02-28
JP2007537242A (ja)	2007-12-20
JO2471B1 (en)	2009-01-20
WO2005107809A8 (fr)	2006-05-18
EP1750765A2 (fr)	2007-02-14
SA05260130B1 (ar)	2008-05-04
BRPI0418770A (pt)	2007-10-09
ATE373488T1 (de)	2007-10-15
KR20070007920A (ko)	2007-01-16
SI1750765T1 (sl)	2008-04-30
CN1956732B (zh)	2010-04-28
AP1994A (en)	2009-04-09
NI200600270A (es)	2007-12-11
UY28893A1 (es)	2005-12-30

Publication	Publication Date	Title
AR025055A1 (es)	2002-11-06	Composiciones farmaceuticas
NO20043913L (no)	2004-11-16	Blandinger med modifisert frigjoring av i det minste en form av tramadol
GEP20053600B (en)	2005-08-10	3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
MXPA05012248A (es)	2006-02-10	Fenil quinolinas y su uso como moduladores del receptor de estrogeno.
UA94390C2 (ru)	2011-05-10	Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких
TR200200795T2 (tr)	2002-07-22	5-HT1B antagonistleri olarak piperazin türevleri
DE60119397D1 (de)	2006-06-08	"2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
TR200201505T2 (tr)	2003-01-21	Terapötik maddeler olarak pirazolopirimidinler
TR199802273T2 (xx)	2000-11-21	Fibrotik lezyonlar�n onar�lmas� ve �nlenmesi.
PH12021550687A1 (en)	2022-02-14	Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
ATE495187T1 (de)	2011-01-15	Dalda-analoge und ihre verwendung
CY1110906T1 (el)	2015-06-10	Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
ECSP055701A (es)	2005-05-30	Nuevos derivados de pirimidinamida y el uso de los mismos
ATE288747T1 (de)	2005-02-15	Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
HRP20070574T3 (en)	2008-01-31	Antimycobacterial pharmaceutical composition comprising an antitubercular drug
TW200624431A (en)	2006-07-16	Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
TR200100895T2 (tr)	2001-12-21	Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
UY27416A1 (es)	2003-03-31	Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana
DK0777653T3 (da)	2001-10-08	Dihydropyridinderivater som bradykininantagonister
BRPI0409379A (pt)	2006-04-25	combinações de paroxetina e 1-(r)-(3-,5-bis-trifluormetil-fenil)-etil] metilamida do ácido (s)-(4-flúor-2-metil-fenil)-piperazina-1-carboxìlico para tratamento de depressão e/ou ansiedade
TW200638927A (en)	2006-11-16	Bambuterol and integrin inhibitor combination
EA200702386A1 (ru)	2008-04-28	Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
TW200602329A (en)	2006-01-16	Novel diazine derivatives, their manufacture and use as pharmaceutical agents
FR2875499B1 (fr)	2006-10-27	Nouveaux derives pyridiniques d'indolin-2-one, leur preparation et leur application en therapeutique